AARD
Aardvark Therapeutics
AARD
AARD
79 hedge funds and large institutions have $38.5M invested in Aardvark Therapeutics in 2026 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
73% less capital invested
Capital invested by funds: $141M → $38.5M (-$103M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $313K
Holders
79
Holding in Top 10
1
Calls
–
Puts
$313K
Top Buyers
| 1 | +$3.28M | |
| 2 | +$3.11M | |
| 3 | +$1.39M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.36M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$751K |
Top Sellers
| 1 | -$6.26M | |
| 2 | -$3.99M | |
| 3 | -$2.8M | |
| 4 |
SCM
Superstring Capital Management
New York
|
-$912K |
| 5 |
CC
Centiva Capital
New York
|
-$754K |
